Kynurenic acid (KYNA), a glial-derived metabolite of
tryptophan metabolism, is an antagonist of the alpha 7
nicotinic acetylcholine receptor and the
glycine-binding site of
N-methyl-d-aspartate (
NMDA) receptors.
Kynurenic acid levels are increased in both the brain and cerebrospinal fluid of several
psychiatric disorders including
bipolar disorder,
schizophrenia, and
Alzheimer disease. In addition, pro-inflammatory
cytokines have been found to be elevated in the blood of schizophrenic patients suggesting
inflammation may play a role in
psychiatric illness. As both pro-inflammatory
cytokines and KYNA can be elevated in the brain by peripheral
lipopolysaccharide (LPS) injection, we therefore sought to characterize the role of
neuroinflammation on learning and memory using a well-described dual-LPS injection model. Mice were injected with an initial injection (0.25 mg/kg LPS, 0.50 mg/kg, or saline) of LPS and then administrated a second injection 16 hours later. Our results indicate both 0.25 and 0.50 mg/kg dual-LPS treatment increased l-
kynurenine and KYNA levels in the medial pre-frontal cortex (mPFC). Mice exhibited impaired acquisition of CS+ (conditioned stimulus) Pavlovian conditioning. Notably, mice showed impairment in reference memory while working memory was normal in an 8-arm maze. Taken together, our findings suggest that
neuroinflammation induced by peripheral LPS administration contributes to
cognitive dysfunction.